Healthcare Analyst Tsai, along with expert pulmonologist, Dr. Robert Aris, discuss Chronic obstructive pulmonary disease (COPD) (relevant companies VRNA, AMGN, NVS, GSK, AZN, REG) on an Analyst/Industry conference call to be held on May 24 at 11 am.Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNA:
- Verona Pharma announces $650M strategic financing with Oaktree, OMERS
- Verona Pharma reports Q1 EPS (4c), consensus (16c)
- Verona Pharma Plc Secures Funding and Negotiates Sales Milestones
- Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS